Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Jun. 30, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 386.4	$ 378.1
Accounts receivable, less allowance for credit losses	1,282.1	1,259.6
Inventories	2,122.7	2,148.0
Prepaid expenses and other current assets	671.7	597.7
Current assets of discontinued operations		501.6
Total Current Assets	4,462.9	4,885.0
Property, plant and equipment, net	1,796.6	1,836.6
Goodwill	8,868.9	8,919.4
Intangible assets, net	5,304.4	5,533.6
Other assets	1,019.9	1,005.0
Noncurrent assets of discontinued operations		1,276.8
Total Assets	21,452.7	23,456.4
Current Liabilities:
Accounts payable	307.1	306.5
Income taxes payable	37.5	62.0
Salaries, wages and benefits	233.2	317.6
Other current liabilities	1,033.9	999.5
Current portion of long-term debt	851.9	1,605.1
Current liabilities of discontinued operations		177.2
Total Current Liabilities	2,463.6	3,467.9
Deferred income taxes, net	526.2	558.5
Long-term income tax payable	591.0	583.0
Other long-term liabilities	575.3	548.5
Long-term debt	5,172.0	5,463.7
Noncurrent liabilities of discontinued operations		168.4
Total Liabilities	9,328.1	10,790.0
Commitments and Contingencies (Note 16)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 313.4 million shares in 2022 (312.8 million in 2021) issued	3.1	3.1
Paid-in capital	9,418.8	9,314.8
Retained earnings	9,606.5	10,292.2
Accumulated other comprehensive loss	(192.5)	(231.6)
Treasury stock, 103.8 million shares in 2022 (103.8 million shares in 2021)	(6,717.5)	(6,717.8)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,118.4	12,660.7
Noncontrolling interest	6.2	5.7
Total Stockholders' Equity	12,124.6	12,666.4
Total Liabilities and Stockholders' Equity	$ 21,452.7	$ 23,456.4